Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.3B | 7.2B | 7.9B | 7.8B |
Cost of revenue | 5.9B | 5.9B | 6.2B | 6.2B |
Gross profit | 1.4B | 1.4B | 1.7B | 1.6B |
Operating expense | ||||
Research & development | 153.4M | 146.6M | 163.6M | 159.4M |
Selling general and admin | 74.1M | 81.8M | 68.2M | 76.7M |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 1.1B | 1.4B | 1.4B |
Non operating interest income | ||||
Income | 26.4M | 30.7M | 38.3M | 44.3M |
Expense | 121.0M | 125.3M | 111.6M | 115.9M |
Other income expense | 43.5M | -139.8M | -184.1M | -46.0M |
Pretax income | 1.1B | 905.9M | 1.2B | 1.3B |
Tax provision | 202.0M | 199.4M | 229.2M | 246.3M |
Net income | 893.1M | 706.5M | 952.8M | 1.0B |
Basic EPS | 0.8 | 0.6 | 0.8 | 0.8 |
Diluted EPS | 0.7 | 0.6 | 0.8 | 0.8 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 1.8B | 1.8B | 1.5B | 2.0B |
Net income from continuing op. | 893.1M | 706.5M | 952.8M | 1.0B |
Minority interests | -29.0M | -27.3M | -19.6M | -27.3M |
Preferred stock dividends | — | — | — | — |